Detalles de la búsqueda
1.
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Lancet
; 403(10432): 1164-1175, 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402887
2.
Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium.
J Infect Dis
; 226(2): 287-291, 2022 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33367918
3.
A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania.
J Infect Dis
; 223(1): 119-127, 2021 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32621741
4.
Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
Clin Infect Dis
; 67(suppl_1): S35-S41, 2018 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30376081
5.
Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
Clin Infect Dis
; 67(suppl_1): S57-S65, 2018 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30376095
6.
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial.
Lancet
; 388(10040): 158-69, 2016 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27212429
7.
Novel Oral Polio Vaccine Type 2 Use for Polio Outbreak Response: A Global Effort for a Global Health Emergency.
Pathogens
; 13(4)2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38668228
8.
Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.
Lancet Infect Dis
; 24(3): 275-284, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109921
9.
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience.
Vaccine
; 41 Suppl 1: A122-A127, 2023 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307230
10.
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study.
Vaccine
; 41(10): 1657-1667, 2023 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746739
11.
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials.
Lancet Microbe
; 3(12): e912-e921, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332645
12.
Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges.
Front Immunol
; 13: 788619, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35273592
13.
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.
NPJ Vaccines
; 7(1): 19, 2022 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35149714
14.
Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial.
Lancet Infect Dis
; 21(4): 559-568, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33284114
15.
Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses.
NPJ Vaccines
; 6(1): 94, 2021 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326330
16.
Model Systems to Study the Chronic, Polymicrobial Infections in Cystic Fibrosis: Current Approaches and Exploring Future Directions.
mBio
; 12(5): e0176321, 2021 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34544277
17.
Hospital resource utilization with doripenem versus imipenem in the treatment of ventilator-associated pneumonia.
Clin Ther
; 30(4): 717-33, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18498921
18.
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
Vaccine
; 35(52): 7283-7291, 2017 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29150209
19.
Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV.
Pediatr Infect Dis J
; 35(10): 1137-9, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27254033
20.
Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants.
Lancet Infect Dis
; 16(12): 1377-1384, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27638357
Resultados
1 -
20
de 20
1
Próxima >
>>